2021 Cilt 19 Sayı 3
Permanent URI for this collectionhttps://hdl.handle.net/11452/27894
Browse
Browsing by Author "Çam, Halit"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
Item Patterns of myocardial involvement during COVID-19 pandemic; From newborn to adolescents(Galenos Yayıncılık, 2021-11-11) Tunçer, Tunç; Varol, Fatih; Coşkun, Şenay; Güzel, Bülent; Güven, Şirin; Çam, HalitIntroduction: Coronavirus 2 (SARS-CoV-2) has infected people of all ages all across the world, with children accounting for 1.7 percent of cases. Despite the fact that over 90% of children with COVID-19 had asymptomatic, mild, or moderate disease, new worries about hyperinflammatory states or Kawasaki-like disease have surfaced. Materials and Methods: We would like to present 17 patients with different patterns of myocardial involvement. They were selected from our database of 214 patients (19 newborns) hospitalized for SARS-CoV-2 infection treatment in our pediatrics clinic from March 2020 to October 2020. Selection criteria involved cardiac involvement in terms of positive laboratory findings (elevated troponin I) electrocardiographic and echocardiographic findings. Results: Cardiac involvement was detected in only 17 (7.9%) of the 214 hospitalized patients. Patients were grouped into three categories according to their hospitalization units which were neonatal intensive care, pediatric intensive care and pediatric inpatient clinic. Most of our patients (88.2%) had elevated troponin I levels whereas 12 patients (70.5%) had abnormal electrocardiograms and echocardiographic exams. Fourteen (82.3%) of patients with high troponin I levels had also abnormal electrocardiograms whereas 13 (76.4%) of them had abnormal echocardiographic exams. Conclusion: Although we did not observe cardiac involvement in most of the patients (92.1%) hospitalized for SARS-CoV-2 infection treatment in our pediatrics clinic, subjects with involvement had quite diverse patterns ranging from only troponin I elevation to the multisystem inflammatory syndrome in children needing arteriovenous extracorporeal membrane oxygenation therapy.